Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)

CompletedOBSERVATIONAL

Enrollment

382

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Prostatic Neoplasms

Interventions

OTHER

No Intervention

Medical charts of participants with metastatic castration-resistant prostate cancer will be observed.

Trial Locations (10)

Brasília

Curitiba

Distrito Federal

Florianópolis

Goiânia

Ijuí

Jaú

Porto Alegre

Rio de Janeiro

São Paulo

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT02230059 - Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC) | Biotech Hunter | Biotech Hunter